Literature DB >> 1597197

Pneumonia in childhood: etiology and response to antimicrobial therapy.

O Ruuskanen1, H Nohynek, T Ziegler, R Capeding, H Rikalainen, P Huovinen, M Leinonen.   

Abstract

A prospective eight-month study was carried out in 50 children admitted to hospital for radiologically confirmed community-acquired pneumonia. A potential causative agent of infection was identified in 44 (88%) cases. Using virus isolation, virus antigen detection and enzyme immunoassay serology, respiratory virus infection was diagnosed in 30 (60%) patients. Antibody assays for seven bacteria and antigen detection from serum and urine for Streptococcus pneumoniae produced evidence of bacterial infection in 31 (62%) cases. Streptococcus pneumoniae (38%), respiratory syncytial virus (30%) and Mycoplasma pneumoniae (20%) were the most common causative agents. A mixed infection was diagnosed in 25 (50%) episodes. Nine patients failed to respond to antibiotics within 24 h after onset of treatment. Three of them had a pure viral infection, three a mixed viral-bacterial infection, two a Mycoplasma pneumoniae infection mixed with other bacteria and one a pure Mycoplasma pneumoniae infection. All three Mycoplasma pneumoniae infections were initially treated with penicillin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1597197     DOI: 10.1007/bf02098083

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  34 in total

1.  A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.

Authors:  J Eskola; H Käyhty; A K Takala; H Peltola; P R Rönnberg; E Kela; E Pekkanen; P H McVerry; P H Mäkelä
Journal:  N Engl J Med       Date:  1990-11-15       Impact factor: 91.245

2.  Bacterial coinfection in children hospitalized with respiratory syncytial virus infections.

Authors:  M Korppi; M Leinonen; M Koskela; P H Mäkelä; K Launiala
Journal:  Pediatr Infect Dis J       Date:  1989-10       Impact factor: 2.129

3.  Rhinovirus as a lower respiratory tract pathogen in infants.

Authors:  H J Schmidt; R J Fink
Journal:  Pediatr Infect Dis J       Date:  1991-09       Impact factor: 2.129

4.  Problems in determining the etiology of community-acquired childhood pneumonia.

Authors:  D Isaacs
Journal:  Pediatr Infect Dis J       Date:  1989-03       Impact factor: 2.129

5.  Rapid diagnosis of Mycoplasma pneumoniae infection: clinical evaluation of a commercial probe test.

Authors:  S R Kleemola; J E Karjalainen; R K Räty
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

6.  Acute maxillary sinusitis in children.

Authors:  E R Wald; G J Milmoe; A Bowen; J Ledesma-Medina; N Salamon; C D Bluestone
Journal:  N Engl J Med       Date:  1981-03-26       Impact factor: 91.245

7.  Time-resolved fluoroimmunoassay with monoclonal antibodies for rapid diagnosis of influenza infections.

Authors:  H H Walls; K H Johansson; M W Harmon; P E Halonen; A P Kendal
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

8.  IgM antibodies specific for Epstein-Barr virus in infectious mononucleosis without heterophil antibodies.

Authors:  J Nikoskelainen; J Leikola; E Klemola
Journal:  Br Med J       Date:  1974-10-12

9.  Use of bacterial antigen detection in the diagnosis of pediatric lower respiratory tract infections.

Authors:  B W Ramsey; E K Marcuse; H M Foy; M K Cooney; I Allan; D Brewer; A L Smith
Journal:  Pediatrics       Date:  1986-07       Impact factor: 7.124

10.  Rhinovirus in acute otitis media.

Authors:  M Arola; T Ziegler; O Ruuskanen; J Mertsola; K Näntö-Salonen; P Halonen
Journal:  J Pediatr       Date:  1988-10       Impact factor: 4.406

View more
  21 in total

Review 1.  New pneumococcal vaccines for children.

Authors:  S Choo; A Finn
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

2.  British Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Childhood.

Authors: 
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

3.  Etiology and response to antibiotic therapy of community-acquired pneumonia in French children.

Authors:  D Gendrel; J Raymond; F Moulin; J L Iniguez; S Ravilly; F Habib; P Lebon; G Kalifa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

Review 4.  Clinical use of cefuroxime in paediatric community-acquired pneumonia.

Authors:  C Olivier
Journal:  Paediatr Drugs       Date:  2000 Sep-Oct       Impact factor: 3.022

5.  Severe Mycoplasma disease--rare or underdiagnosed?

Authors:  G H Cassell
Journal:  West J Med       Date:  1995-02

6.  Procalcitonin in children admitted to hospital with community acquired pneumonia.

Authors:  F Moulin; J Raymond; M Lorrot; E Marc; J Coste; J L Iniguez; G Kalifa; C Bohuon; D Gendrel
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

Review 7.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 8.  Community-acquired pneumonia in children: issues in optimizing antibacterial treatment.

Authors:  Matti Korppi
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

9.  Prediction of delayed recovery from pediatric community-acquired pneumonia.

Authors:  Massimiliano Don; Francesca Valent; Mario Canciani; Matti Korppi
Journal:  Ital J Pediatr       Date:  2010-07-29       Impact factor: 2.638

10.  Diagnosis of Mycoplasma pneumoniae pneumonia in children.

Authors:  M E Waris; P Toikka; T Saarinen; S Nikkari; O Meurman; R Vainionpää; J Mertsola; O Ruuskanen
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.